Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neurotensin receptor 3 (NTS3), also known as sortilin, is a type I receptor that binds neurotensin and other ligands. It plays diverse roles in cellular function, including cell migration, insulin secretion, and cell adhesion. NTS3 is implicated in various physiological processes and pathological conditions such as cancer, diabetes, and neurological disorders. Unlike NTS1 and NTS2, it is not a G protein-coupled receptor and requires propeptide cleavage for activation.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neurotensin Receptor 3 (NTS3).